Advertisement - Members don't see this ad
Looks like RefleXion may basically be done. A Glassdoor post from 8/25, supposedly from their Director of QA, says they laid off almost everyone on 8/21 and are down to ~45 people from >300 a few years ago. Apparently only 12 systems were ever sold, and some of the remaining staff are just dealing with source returns, chillers, and shutdown-type work.
Obviously Glassdoor is anonymous, and I haven’t seen an actual bankruptcy filing yet, but this sounds a lot more like winding the place down than “restructuring.”
Not that surprising. The machine was fascinating technology that solved a problem I was never convinced actually mattered clinically. And requiring repeated FDG injections to make the whole thing work was always a little insane. Very cool engineering. Very questionable clinical value proposition.
Obviously Glassdoor is anonymous, and I haven’t seen an actual bankruptcy filing yet, but this sounds a lot more like winding the place down than “restructuring.”
Not that surprising. The machine was fascinating technology that solved a problem I was never convinced actually mattered clinically. And requiring repeated FDG injections to make the whole thing work was always a little insane. Very cool engineering. Very questionable clinical value proposition.
RefleXion Medical — Glassdoor review, Aug. 25, 2026
Reviewer identifies themselves as Director of Quality Assurance.
Reports that on Aug. 21, 2026, RefleXion terminated essentially the remaining workforce, leaving approximately 45 employees, down from more than 300 several years ago. The reviewer states that only 12 systems were sold and describes remaining activities as including return of radioactive sources, chillers, and other shutdown-related work. The overall characterization is that the company’s doors are effectively closed.